Developmental implications of ocular pharmacology.
D000328:Adult; D000368:Aged; D000375:Aging / Q000187:drug effects; D000437:Alcoholism / Q000188:drug therapy; D000596:Amino Acids / Q000502:physiology; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001082:Aqueous Humor / Q000502:physiology; D001341:Autonomic Nervous System / Q000187:drug effects; D001693:Biological Transport, Active; D001923:Brain Chemistry / Q000187:drug effects; D002301:Cardiac Glycosides / Q000494:pharmacology; D002395:Catecholamines / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003930:Diabetic Retinopathy / Q000188:drug therapy; D004815:Epidermal Growth Factor / Q000502:physiology; D005123:Eye / Q000098:blood supply / Q000187:drug effects* / Q000254:growth & development / Q000276:immunology; D005342:Fibrinolysis / Q000187:drug effects; D005901:Glaucoma / Q000188:drug therapy; D006099:Granuloma / Q000209:etiology; D006111:Graves Disease / Q000188:drug therapy / Q000503:physiopathology; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007111:Immunity, Cellular / Q000187:drug effects; D007223:Infant; D007231:Infant, Newborn; D007975:Leukotriene B4 / Q000502:physiology; D008661:Metabolism, Inborn Errors / Q000188:drug therapy / Q000235:genetics; D009103:Multiple Sclerosis / Q000188:drug therapy; D009126:Muscle Relaxation / Q000187:drug effects; D009747:Nutritional Physiological Phenomena / Q000187:drug effects; D010100:Oxygen / Q000633:toxicity; D010101:Oxygen Consumption / Q000187:drug effects; D010857:Pigment Epithelium of Eye / Q000187:drug effects; D010870:Pineal Gland / Q000254:growth & development; D011448:Prostaglandin Antagonists / Q000494:pharmacology; D011453:Prostaglandins / Q000502:physiology; D011619:Psychotropic Drugs / Q000494:pharmacology; D012160:Retina / Q000098:blood supply / Q000187:drug effects / Q000254:growth & development; D012162:Retinal Degeneration / Q000188:drug therapy; D013189:SRS-A / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D012907:Smoking; D013312:Stress, Physiological / Q000503:physiopathology; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000596:Amino Acids; D000779:Anesthetics, Local; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D002301:Cardiac Glycosides; D002395:Catecholamines; D006213:Hallucinogens; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011619:Psychotropic Drugs; D013189:SRS-A; D007975:Leukotriene B4; D012701:Serotonin; D004815:Epidermal Growth Factor; D010100:Oxygen